Compounds > 4,5,6,7-tetrabromo-2-azabenzimidazole

4,5,6,7-tetrabromo-2-azabenzimidazole and quercetin

4,5,6,7-tetrabromo-2-azabenzimidazole has been researched along with quercetin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bain, J; Battistutta, R; de Moliner, E; Elliott, M; Fabbro, D; Furet, P; Meggio, F; Pagano, MA; Pinna, LA; Ruzzene, M; Sarno, S; Schoepfer, J; Zanotti, G1
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Chen, T; Chen, Y; Feng, F; Guo, Q; Lin, H; Liu, W; Liu, Z; Qiao, Y; Qu, W; Sun, H; Yang, H1
Alinger, B; Berr, F; Di Fazio, P; Fuereder, J; Kiesslich, T; Neureiter, D; Oberdanner, C; Ocker, M; Pichler, M; Wachter, J1

Reviews

1 review(s) available for 4,5,6,7-tetrabromo-2-azabenzimidazole and quercetin

ArticleYear
Small molecule modulators targeting protein kinase CK1 and CK2.
    European journal of medicinal chemistry, 2019, Nov-01, Volume: 181

    Topics: Animals; Casein Kinase I; Casein Kinase II; Drug Discovery; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Small Molecule Libraries

2019

Other Studies

3 other study(ies) available for 4,5,6,7-tetrabromo-2-azabenzimidazole and quercetin

ArticleYear
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
    The Biochemical journal, 2003, Sep-15, Volume: 374, Issue:Pt 3

    Topics: Acetates; Animals; Casein Kinase II; Cell Line; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Jurkat Cells; Molecular Structure; Plant Proteins; Protein Serine-Threonine Kinases; Protein Structure, Quaternary; Quinazolines; Rats; Zea mays

2003
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Influence of five potential anticancer drugs on wnt pathway and cell survival in human biliary tract cancer cells.
    International journal of biological sciences, 2012, Volume: 8, Issue:1

    Topics: Antineoplastic Agents; Benzimidazoles; beta Catenin; Biliary Tract Neoplasms; Cadherins; Cell Line, Tumor; Cell Survival; Clinical Trials as Topic; Cyclin D1; Flavonoids; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Ki-67 Antigen; Proliferating Cell Nuclear Antigen; Quercetin; RNA, Messenger; Sulfonamides; Triazoles; Vimentin; Wnt Signaling Pathway

2012